Schizophrenia is a serious neuropsychiatric illness estimated to affect approximately 1% of the general population. Family, twin and adoption studies have demonstrated that schizophrenia is predominantly a genetic disorder, with a high heritability. Segregation analyses have failed to clearly support a single model of inheritance and suggest at least several, possibly interacting, susceptibility loci. We have previously identified a strong linkage signal (hlod=6.5, empirical p less than 0.0002) to 1q22 in a set of medium-sized Canadian families, selected for study because multiple relatives were clinically diagnosed with schizophrenia or schizoaffective disorder. Fine-map linkage analysis has identified an approximately 1.3 Mb interval that appears very likely to harbor the susceptibility gene, with a 300 kb sub-region identified by linkage as most likely to contain the gene. We have further identified significant linkage disequilibrium (LD) within a 100 kb portion of this sub-interval. The region of LD is contained within the over 300 kb genomic extent of the gene ICAPON, and there is evidence that additional genes may exist within the introns of this large gene. We plan to search this region for additional transcribed sequences to screen for variants associated with schizophrenia susceptibility. We also plan to use comparative genomic techniques to identify conserved regulatory regions within this area. These will also be assessed for variation that is associated with schizophrenia susceptibility. The sample with strong linkage to this region will first be tested for LD, with the NIMH-HGI collection and a Canadian case-control sample also genotyped with markers producing significant LD in the linkage sample. We also plan to conduct expression studies of protein and RNA, using RNA from the Stanley Array Collection, post-mortem brains from the Harvard Brain Bank, and lymphoblastoid cell lines from our linkage sample and the NIMH-HGI collection. We hope to use our investigations of this locus in this sample as a testbed for refining a comprehensive approach to susceptibility gene identification, combining linkage and linkage disequilibrium mapping, evolutionary based sequence comparison methods, and complementary gene expression studies. We anticipate that these methods will be of future use for finding additional susceptibility genes for schizophrenia and other complex disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH062440-08
Application #
7347563
Study Section
Genome Study Section (GNM)
Program Officer
Koester, Susan E
Project Start
2001-02-01
Project End
2010-01-31
Budget Start
2008-02-01
Budget End
2010-01-31
Support Year
8
Fiscal Year
2008
Total Cost
$497,288
Indirect Cost
Name
Rutgers University
Department
Genetics
Type
Schools of Arts and Sciences
DUNS #
001912864
City
New Brunswick
State
NJ
Country
United States
Zip Code
08901
Carrel, Damien; Hernandez, Kristina; Kwon, Munjin et al. (2015) Nitric oxide synthase 1 adaptor protein, a protein implicated in schizophrenia, controls radial migration of cortical neurons. Biol Psychiatry 77:969-78
Husted, Janice A; Ahmed, Rashid; Chow, Eva W C et al. (2012) Early environmental exposures influence schizophrenia expression even in the presence of strong genetic predisposition. Schizophr Res 137:166-8
Husted, Janice A; Ahmed, Rashid; Chow, Eva W C et al. (2010) Childhood trauma and genetic factors in familial schizophrenia associated with the NOS1AP gene. Schizophr Res 121:187-92
Bassett, Anne S; Scherer, Stephen W; Brzustowicz, Linda M (2010) Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease. Am J Psychiatry 167:899-914
Hadzimichalis, Norell M; Previtera, Michelle L; Moreau, Michael P et al. (2010) NOS1AP protein levels are altered in BA46 and cerebellum of patients with schizophrenia. Schizophr Res 124:248-50
Carrel, Damien; Du, Yangzhou; Komlos, Daniel et al. (2009) NOS1AP regulates dendrite patterning of hippocampal neurons through a carboxypeptidase E-mediated pathway. J Neurosci 29:8248-58
Wratten, Naomi S; Memoli, Holly; Huang, Yungui et al. (2009) Identification of a schizophrenia-associated functional noncoding variant in NOS1AP. Am J Psychiatry 166:434-41
Ng, M Y M; Levinson, D F; Faraone, S V et al. (2009) Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry 14:774-85
Kremeyer, Barbara; García, Jenny; Kymäläinen, Hanna et al. (2009) Evidence for a role of the NOS1AP (CAPON) gene in schizophrenia and its clinical dimensions: an association study in a South American population isolate. Hum Hered 67:163-73
Brzustowicz, Linda M; Bassett, Anne S (2008) Phenotype matters: the case for careful characterization of relevant traits. Am J Psychiatry 165:1096-8

Showing the most recent 10 out of 23 publications